Potent Inhibitory Effects of Type I Interferons on Human Adrenocortical Carcinoma Cell Growth
Author(s) -
Peter M. van Koetsveld,
Giovanni Vitale,
Wouter W. de Herder,
Richard A. Feelders,
Katy van der Wansem,
Marlijn Waaijers,
Casper H.J. van Eijck,
ErnstJan M. Speel,
Ed Croze,
AartJan van der Lely,
Steven W. J. Lamberts,
Leo J. Hofland
Publication year - 2006
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-0620
Subject(s) - adrenocortical carcinoma , apoptosis , cell growth , endocrinology , medicine , cell culture , growth inhibition , cell cycle , cell , ic50 , biology , cancer research , cancer , biochemistry , genetics
Adrenocortical carcinoma (ACC) is a rare tumor with a poor prognosis. Despite efforts to develop new therapeutic regimens for metastatic ACC, surgery remains the mainstay of treatment. Interferons are known to exert tumor-suppressive effects in several types of human cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom